- Dividend Yield (FWD)
- 1.88%
- Annual Payout (FWD)
- €9.85
- Dividend Growth Rate (CAGR)
As an aristocrat you get access to the dividend growth rate and all important dividend figures tailored to your portfolio.
| Ex-Date | Pay Date | Amount | Change |
|---|---|---|---|
| €9.85 | 429.57% | ||
| €9.85 | 429.57% | ||
| €1.86 | 675% | ||
| €1.86 | 675% | ||
| €0.24 | -81.82% | ||
| €1.32 | -45% | ||
| €2.40 | |||
DekaLux-BioTech CF pays a dividend yield (FWD) of 1.88%.
- ISIN
- WKN
- Symbol / Exchange
- / -
- Value
- €523.69
- Dividend frequency
- annually
- Security Type
- Fund
- Dividend Currency
- Euro
- Countries
- United States85.85%
- United Kingdom4.21%
- France2.82%
- Germany1.91%
- Denmark1.55%
- China1.17%
- Switzerland0.74%
- Japan0.57%
- Canada0.41%
- Sweden0.41%
- Netherlands0.20%
- Ireland0.15%
- Sectors
- Health Care100.00%
Similar securities
Those who hold DekaLux-BioTech CF often invest in these securities as well.
- Within the last 12 months, DekaLux-BioTech CF paid a dividend of €9.85. For the next 12 months, DekaLux-BioTech CF is expected to pay a dividend of €9.85. This corresponds to a dividend yield of approximately 1.88%.
- The dividend yield of DekaLux-BioTech CF is currently 1.88%.
- DekaLux-BioTech CF pays annually dividends. Payout is in August.
- The next dividend for DekaLux-BioTech CF is expected in August.
- Within the last 10 years, DekaLux-BioTech CF has paid dividends in 5 of them.
- Dividends of €9.85 are expected for the next 12 months. This corresponds to a dividend yield of 1.88%.
- The largest sectors of DekaLux-BioTech CF are Health Care, Financials, Real Estate.
- There are currently no known stock splits for DekaLux-BioTech CF.
- To receive the last dividend of DekaLux-BioTech CF on August 18, 2023 in the amount of €9.85 you had to have the stock in your portfolio before the ex-day on August 17, 2023.
- The last dividend was paid on August 18, 2023.
- In 2022, dividends of €1.86 were paid by DekaLux-BioTech CF.
- Dividends from DekaLux-BioTech CF are paid in Euro.
- In DekaLux-BioTech CF, the United States, the United Kingdom and France are represented as the three largest countries.